On the other hand, other studies report that canonical NOTCH pathway is needed for the tumorigenesis of KRASG12V driven NSCLC and that pharmacological inhibition with GSI arrests tumor growth partly via activation of DUSP1 and consequent dephosphorylation of ERK specifically (not MEK) (45). This evidence concerns the gene MAP2K7 and non-small cell lung carcinoma.